Relationship between the adipose-tissue hormone resistin and coronary artery disease

Clinica Chimica Acta

Volumn 386, Issue 1-2, 2007, Pages 1-6

  Hoefle, Guenter ^a   Saely, Christoph H ^a,b   Risch, Lorenz ^b   Koch, Lorena ^b   Schmid, Fabian ^b   Rein, Philipp ^a,b   Aczél, Stefan ^a,b   Berchtold, Sabine ^c   Drexel, Heinz ^a,b,d  

^a ACADEMIC TEACHING HOSPITAL FELDKIRCH   (Austria)

^b Vorarlberg Institute for Vascular Investigation and Treatment   (Austria)

^c LMZ Laboratories   (Liechtenstein)

^d University of Human Sciences   (Liechtenstein)

Author keywords

Adipocytokines; Coronary artery disease; Epidemiology; Obesity; Resistin; Vascular events

Indexed keywords

C REACTIVE PROTEIN; RESISTIN;

ADIPOSE TISSUE; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; FEMALE; HORMONE BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS;

ADIPOSE TISSUE; AGE FACTORS; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RESISTIN; RISK ASSESSMENT; RISK FACTORS;

EID: 34548802452     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.07.001     Document Type: Article

References (29)

1. Steppan C.M., Brown E.J., Wright C.M., et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 98 (2001) 502-506
2. Yannakoulia M., Yiannakouris N., Bluher S., Matalas A.L., Klimis-Zacas D., and Mantzoros C.S. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88 (2003) 1730-1736
3. Vozarova de Courten B., Degawa-Yamauchi M., Considine R.V., and Tataranni P.A. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 53 (2004) 1279-1284
4. Fujinami A., Obayashi H., Ohta K., et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 339 (2004) 57-63
5. Bajaj M., Suraamornkul S., Hardies L.J., Pratipanawatr T., and DeFronzo R.A. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int J Obes Relat Metab Disord 28 (2004) 783-789
6. Pfutzner A., Langenfeld M., Kunt T., Lobig M., and Forst T. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab 49 (2003) 571-576
7. Lee J.H., Chan J.L., Yiannakouris N., et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88 (2003) 4848-4856
8. Fain J.N., Cheema P.S., Bahouth S.W., and Lloyd Hiler M. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 300 (2003) 674-678
9. Patel L., Buckels A.C., Kinghorn I.J., et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300 (2003) 472-476
10. Lu S.C., Shieh W.Y., Chen C.Y., Hsu S.C., and Chen H.L. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 530 (2002) 158-162
11. Verma S., Li S.H., Wang C.H., et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108 (2003) 736-740
12. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 Suppl 1 (2004) II2-II10
13. Efstathiou S.P., Tsiakou A.G., Tsioulos D.I., et al. Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin Chim Acta 378 (2007) 78-85
14. Ohmori R., Momiyama Y., Kato R., et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 46 (2005) 379-380
15. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., and Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932-939
16. Pischon T., Bamberger C.M., Kratzsch J., et al. Association of plasma resistin levels with coronary heart disease in women. Obes Res 13 (2005) 1764-1771
17. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
18. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
19. Drexel H., Amann F.W., Rentsch K., et al. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol 70 (1992) 436-440
20. Drexel H., Amann F.W., Beran J., et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 90 (1994) 2230-2235
21. Antman E., Bassand J.P., Klein W., et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/American College of Cardiology Committee. J Am Coll Cardiol 36 (2000) 959-969
22. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Tumer R.C. Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
23. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
24. Hallan S., Asberg A., Lindberg M., and Johnsen H. Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 44 (2004) 84-93
25. Foundation N.K. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 Suppl.1 (2002) S1-S246
26. Bo S., Gambino R., Pagani A., et al. Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes Relat Metab Disord 29 (2005) 1315-1320
27. Lubos E., Messow C.M., Schnabel R., et al. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis 193 (2007) 121-128
28. Utzschneider K.M., Carr D.B., Tong J., et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 48 (2005) 2330-2333
29. Janke J., Engeli S., Gorzelniak K., Luft F.C., and Sharma A.M. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 10 (2002) 1-5